A Minipress,Vasoflex,Pressin and Hypovase CEP of the European Pharmacopoeia monograph is often referred to as a Minipress,Vasoflex,Pressin and Hypovase Certificate of Suitability (COS). The purpose of a Minipress,Vasoflex,Pressin and Hypovase CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Minipress,Vasoflex,Pressin and Hypovase EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Minipress,Vasoflex,Pressin and Hypovase to their clients by showing that a Minipress,Vasoflex,Pressin and Hypovase CEP has been issued for it. The manufacturer submits a Minipress,Vasoflex,Pressin and Hypovase CEP (COS) as part of the market authorization procedure, and it takes on the role of a Minipress,Vasoflex,Pressin and Hypovase CEP holder for the record. Additionally, the data presented in the Minipress,Vasoflex,Pressin and Hypovase CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Minipress,Vasoflex,Pressin and Hypovase DMF.
A Minipress,Vasoflex,Pressin and Hypovase CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Minipress,Vasoflex,Pressin and Hypovase CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Minipress,Vasoflex,Pressin and Hypovase suppliers with CEP (COS) on PharmaCompass.